Disc Medicine, Inc. (IRON)
75.14
-0.97
(-1.27%)
USD |
NASDAQ |
Nov 20, 16:00
75.16
+0.02
(+0.03%)
After-Hours: 20:00
Disc Medicine Price to Book Value : 4.802 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 4.802 |
| November 19, 2026 | 4.864 |
| November 18, 2026 | 4.984 |
| November 17, 2026 | 4.894 |
| November 16, 2026 | 4.895 |
| November 13, 2026 | 5.113 |
| November 12, 2026 | 5.320 |
| November 11, 2026 | 5.566 |
| November 10, 2026 | 5.410 |
| November 09, 2026 | 5.194 |
| November 06, 2026 | 5.043 |
| November 05, 2026 | 5.015 |
| November 04, 2026 | 5.323 |
| November 03, 2026 | 5.187 |
| November 02, 2026 | 5.025 |
| October 30, 2026 | 5.167 |
| October 29, 2026 | 5.294 |
| October 28, 2026 | 5.318 |
| October 27, 2026 | 5.107 |
| October 26, 2026 | 4.964 |
| October 23, 2026 | 4.762 |
| October 22, 2026 | 4.795 |
| October 21, 2026 | 4.857 |
| October 20, 2026 | 5.080 |
| October 19, 2026 | 5.045 |
| Date | Value |
|---|---|
| October 16, 2026 | 3.633 |
| October 15, 2026 | 3.621 |
| October 14, 2026 | 3.562 |
| October 13, 2026 | 3.618 |
| October 12, 2026 | 3.865 |
| October 09, 2026 | 3.966 |
| October 08, 2026 | 3.884 |
| October 07, 2026 | 3.910 |
| October 06, 2026 | 3.940 |
| October 05, 2026 | 4.048 |
| October 02, 2026 | 4.123 |
| October 01, 2026 | 4.066 |
| September 30, 2026 | 4.184 |
| September 29, 2026 | 3.921 |
| September 28, 2026 | 3.864 |
| September 25, 2026 | 3.884 |
| September 24, 2026 | 3.955 |
| September 23, 2026 | 3.934 |
| September 22, 2026 | 4.076 |
| September 21, 2026 | 4.077 |
| September 18, 2026 | 4.139 |
| September 17, 2026 | 4.118 |
| September 16, 2026 | 4.082 |
| September 15, 2026 | 4.006 |
| September 14, 2026 | 4.103 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 16.42 |
| Anika Therapeutics, Inc. | 1.288 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.268 |
Price to Book Value Related Metrics
| PEG Ratio | -0.6491 |
| Price | 75.14 |
| Earnings Yield | -8.43% |
| Market Cap | 2.902B |
| PEGY Ratio | -0.6491 |